Trials / Sponsors / Prometic Biotherapeutics, Inc.
Prometic Biotherapeutics, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia Hypoplasminogenemia, Congenital Plasminogen Deficiency | Phase 2 / Phase 3 | 2016-05-04 |
| Completed | Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% Primary Immunodeficiency | Phase 3 | 2016-01-26 |
| Completed | A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency Type I Plasminogen Deficiency, Hypoplasminogenemia | Phase 1 | 2014-12-01 |
| No Longer Available | A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous Hypoplasminogenemia | — | — |
| No Longer Available | A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Tri Hypoplasminogenemia | — | — |